Cooperative Research Agreements Related to the World Trade Center Health Program (U01)

Cooperative Research Agreements Related to the World Trade Center Health Program (U01) is sponsored by National Institute for Occupational Safety and Health (NIOSH). This program supports research to improve care and well-being for people exposed to the September 11, 2001 terrorist attacks, including enrolled FDNY responders, and to identify emerging conditions within affected populations.

Opportunity Listing - Cooperative Research Agreements Related to the World Trade Center Health Program (U01) Cooperative Research Agreements Related to the World Trade Center Health Program (U01) Agency: Centers for Disease Control and Prevention - ERA Assistance Listings: 93. 262 -- Occupational Safety and Health Program Last Updated: May 13, 2026 View version history on Grants.

gov The National Institute for Occupational Safety and Health (NIOSH) supports research projects that address: (1) physical and mental health conditions related to the September 11, 2001, terrorist attacks; (2) diagnosing conditions for which there has been diagnostic uncertainty; and (3) treating conditions for which there has been treatment uncertainty.

Conditions may have emerged since the treatment program began or since the WTC Health Program was established. This announcement solicits meritorious and scientifically rigorous applications that will: 1) improve diagnosis and treatment activities...

of the WTC Health Program; 2) expand knowledge about health effects related to the September 11, 2001, terrorist attacks; 3) answer critical questions about WTC-related physical and mental health conditions; and 4) apply lessons learned to improve response to future disasters.

Potential projects may include, but are not limited to: (a) Screening research to evaluate current methods or facilitate the development of new or improved methods to detect disorders or health conditions; (b) Diagnostic research to evaluate current methods or facilitate the development of new or improved methods to identify diseases, disorders, or conditions; (c) Treatment research to evaluate or identify improved treatment interventions or methods, or to promote development of new or novel approaches; (d) Prevention research to identify or evaluate methods and interventions that prevent or mitigate the development or recurrence of diseases or disorders; (e) Quality of life research to identify, develop, or evaluate methods or interventions that improve comfort and quality of life for individuals with chronic illness or multimorbidity; (f) Omics research to improve methods for predicting disorders by identifying and understanding relationships between genes and illness (e.g., phenotypes and biomarkers), including how genetic factors influence disease development or response to treatment; (g) Epidemiologic or clinical research to identify patterns, causes, and control of adverse health effects among the 9/11-exposed population; (h) Health services research to examine access to care, cost of care, and outcomes associated with care delivery; (i) Implementation research to evaluate how research findings are disseminated, adopted, implemented, sustained, and scaled in real-world settings; and (j) Epidemiologic research to investigate emerging conditions where preliminary data suggest, but do not confirm, a causal relationship between 9/11 exposure and the condition.

Examples can be found at https://www. cdc. gov/wtc/received.

html.

Independent school districts Public and state institutions of higher education Private institutions of higher education For-profit organizations other than small businesses Nonprofits non-higher education with 501(c)(3) Other Native American tribal organizations Nonprofits non-higher education without 501(c)(3) Public and Indian housing authorities Federally recognized Native American tribal governments City or township governments Special district governments Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Grantor contact information James Yiin, PhD, Scientific Program Official File name Description Last updated rfa-oh-26-001_rev7. pdf rfa-oh-26-001_rev7.

pdf Link to additional information Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.